Product Name
frataxin (FXN), ELISA Kit
Full Product Name
Mouse Frataxin, mitochondrial, FXN ELISA Kit
Product Synonym Names
Mouse Frataxin; mitochondrial (FXN) ELISA kit; CyaY; FA; FARR; FRDA; MGC57199; X25; ; frataxin
Product Gene Name
FXN elisa kit
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Request Current Manual
3D Structure
ModBase 3D Structure for O35943
Preparation and Storage
Store all reagents at 2-8 degree C
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of FXN elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for FXN purchase
MBS9318033 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the frataxin (FXN) ELISA Kit target analytes in
biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing FXN. The ELISA analytical biochemical technique of the MBS9318033 kit is based on FXN antibody-FXN antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect FXN antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, FXN. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
NCBI/Uniprot data below describe general gene information for FXN. It may not necessarily be applicable to this product.
NCBI Accession #
NP_032070.1
[Other Products]
NCBI GenBank Nucleotide #
NM_008044.2
[Other Products]
UniProt Primary Accession #
O35943
[Other Products]
UniProt Related Accession #
O35943[Other Products]
Molecular Weight
22,924 Da
NCBI Official Full Name
frataxin, mitochondrial
NCBI Official Synonym Full Names
frataxin
NCBI Official Symbol
Fxn [Similar Products]
NCBI Official Synonym Symbols
FA; X25; FARR; Frda
[Similar Products]
NCBI Protein Information
frataxin, mitochondrial; Friedreich ataxia
UniProt Protein Name
Frataxin, mitochondrial
UniProt Gene Name
Fxn [Similar Products]
UniProt Synonym Gene Names
Frda; Fxn [Similar Products]
UniProt Entry Name
FRDA_MOUSE
UniProt Comments for FXN
FXN: Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe(2+) to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity. May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems. Modulates the RNA-binding activity of ACO1. Defects in FXN are the cause of Friedreich ataxia (FRDA). FRDA is an autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region. Belongs to the frataxin family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Motility/polarity/chemotaxis; EC 1.16.3.1; Mitochondrial
Cellular Component: mitochondrion; cell; cytoplasm; cytosol
Molecular Function: ferroxidase activity; 2 iron, 2 sulfur cluster binding; enzyme binding; ferric iron binding; metal ion binding; ferrous iron binding; iron-sulfur cluster binding; oxidoreductase activity
Biological Process: cellular iron ion homeostasis; positive regulation of axon extension; proprioception; ***** walking behavior; protein autoprocessing; embryonic development ending in birth or egg hatching; iron incorporation into metallo-sulfur cluster; positive regulation of lyase activity; transport; positive regulation of cell proliferation; response to iron ion; oxidative phosphorylation; positive regulation of oxidoreductase activity; mitochondrion organization and biogenesis; negative regulation of multicellular organism growth; iron-sulfur cluster assembly; positive regulation of metalloenzyme activity; positive regulation of transferase activity; negative regulation of organ growth; positive regulation of cell growth; iron ion homeostasis; aerobic respiration; ion transport; negative regulation of apoptosis; heme biosynthetic process
Research Articles on FXN
1. these results indicate that IGF-I exerts cell-context neuroprotection in frataxin deficiency that maybe therapeutically effective.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.